|20:23 24/05/2013||Bristol-Myers Squibb (BMY) Shares Cross 3% Yield Mark|
Bristol-Myers Squibb (BMY) Shares Cross 3% Yield Mark
Forbes - 10 hours ago
Looking at the universe of stocks we cover at Dividend Channel, in trading on Friday, shares of Bristol-Myers Squibb Co. (NYSE: BMY) were yielding above the 3% mark based on its quarterly dividend (annualized to $1.40), with the stock changing hands as ...This Metric Says You Are Smart to Sell Bristol Myers Squibb Co. (BMY) - Insider Monkey (blog)
Bristol Myers Squibb Rating Increased to Buy at Citigroup (BMY) - Daily Political
|13:56 23/05/2013||Reveal Insider Trading for Bristol-Myers Squibb, QUALCOMM, EMC, Freeport ...|
Reveal Insider Trading for Bristol-Myers Squibb, QUALCOMM, EMC, Freeport ...
PR Newswire (press release) - May 23, 2013
Bristol-Myers Squibb Co. (NYSE: BMY): By the end of last trading session, the shares of Bristol Myers Squibb (NYSE: BMY) soared US$2.34 (or 5.31%) to US$46.40 with 25.35 million shares exchanged hands, compared to daily average volume of 10.39 ...Bristol-Myers Shares Jump as Analyst Hails New Cancer Treatment Drug - 4-traders (press release)
Cancer drugs to rake in R340bn - iAfrica.com
|16:27 22/05/2013||News Buzz: Capstone Turbine Corporation, Walter Energy Inc, Bristol Myers ...|
News Buzz: Capstone Turbine Corporation, Walter Energy Inc, Bristol Myers ...
Cogo - May 22, 2013
Capstone Turbine Corporation (NASDAQ:CPST) shares jumped 5.08% to $0.904. The company, on April 8, announced that it received an order for thirty-four liquid fuel C30s for use in DesignLine'sEco Saver IV range extended electric buses.
|14:04 20/05/2013||Bristol Myers Squibb Co. (BMY), Pharmacyclics, Inc. (PCYC): Hedging Against ...|
Bristol Myers Squibb Co. (BMY), Pharmacyclics, Inc. (PCYC): Hedging Against ...
Insider Monkey (blog) - May 20, 2013
Sprycel: Developed by Bristol Myers Squibb Co. (NYSE:BMY), Sprycel was approved in 2006 as a second-line treatment for patients who had Philadelphia chromosome-positive (Ph+) ALL or Ph+ CML, and had resistance to prior therapy.
|21:48 16/05/2013||Bristol-Myers Squibb experimental melanoma drugs show early success|
Bristol-Myers Squibb experimental melanoma drugs show early success
The Star-Ledger - NJ.com - May 16, 2013
Saed Hindash/The Star-Ledger. Two drugs from Bristol-Myers Squibb Co. shrank tumors in as many as half of patients with advanced melanoma, according to early research that may pave the way for cocktails that trigger the immune system to destroy cancer.Bristol-Myers shares surge on anticipated melanoma drug results - MarketWatch (blog)
Pair of Studies Show Power of Immune System to Fight Cancer - Fox Business
|20:26 14/05/2013||Bristol-Myers Squibb to Present at UBS Global Health Care Conference|
Bristol-Myers Squibb to Present at UBS Global Health Care Conference
Wall Street Journal (press release) - May 14, 2013
Bristol-Myers Squibb Company (NYSE: BMY) will present at the UBS Global Health Care Conference on Tuesday, May 21, 2013, in New York City.
|16:30 14/05/2013||BRISTOL MYERS SQUIBB CO. : EmergingGrowth.com looks at Small Cap ...|
BRISTOL MYERS SQUIBB CO. : EmergingGrowth.com looks at Small Cap ...
4-traders (press release) - May 14, 2013
Merus Labs International Inc. (NASDAQ: MSLI) (TSX: MSL) is a specialty pharmaceutical company focused on the licensing and acquisition of recognized products that are under-promoted from larger pharmaceuticals.
|15:37 08/05/2013||BRISTOL MYERS SQUIBB CO. : Bristol-Myers Squibb to Present at Bank of ...|
BRISTOL MYERS SQUIBB CO. : Bristol-Myers Squibb to Present at Bank of ...
4-traders (press release) - May 8, 2013
Bristol-Myers Squibb Company (NYSE: BMY) will present at Bank of America Merrill Lynch Health Care Conference on Wednesday, May 15, 2013, in Las Vegas.
|14:39 07/05/2013||The Zacks Analyst Blog Highlights: Bristol-Myers Squibb, Sanofi, AbbVie ...|
The Zacks Analyst Blog Highlights: Bristol-Myers Squibb, Sanofi, AbbVie ...
Wall Street Journal (press release) - May 7, 2013
Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Bristol-Myers Squibb Company (NYSE:BMY), Sanofi (NYSE:SNY), AbbVie (NYSE:ABBV) ...
|12:38 25/04/2013||Bristol-Myers Squibb Co. (BMY) Reports In-Line Q1 EPS; Reaffirms|
Bristol-Myers Squibb Co. (BMY) Reports In-Line Q1 EPS; Reaffirms
StreetInsider.com (subscription) - Apr 25, 2013
... and have been preparing for the presentation of key clinical data across our pipeline." Bristol-Myers Squibb Co. sees FY2013 EPS of $1.78-1.88, versus the consensus of $1.83. For earnings history and earnings-related data on Bristol-Myers Squibb Co.Bristol-Myers Squibb Profit Plunges On Patent Expiries Of Cardiovascular Drugs - NASDAQ
Bristol-Myers Profit Drops 45% on Lower Heart Drug Sales - Fox Business